ImClone studying Bristol-Myers Squibb’s offer

SAN FRANCISCO (MarketWatch) — ImClone Systems Inc. late Thursday confirmed it received an offer from Bristol-Myers Squibb . However, other than stating that it is studying the “situation,” the company did not offer any other comments. Bristol-Myers Squibb has offered to buy the shares of ImClone that it does not already own for $60 a share or a total of $4.5 billion. Bristol-Myers has owned about 17% of ImClone since September 2001. Carl Icahn, the billionaire investor activist, is chairman of ImClone.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

More @ DollarDrops.com:MBIA Cuts Bonus Payments To Executives >MBI

MBIA cuts executive bonuses, ups salaries

MBIA Expects Loss Payments Of $700M-$800M For 2008 >MBI

MBIA sells municipal bonds to raise cash: report

Davis Selected Advisers reports 5.1% stake in MBIA Inc.

Original post by Forextvblog

Leave a Reply